Exact Sciences Corporation
EXAS
Classifica tra le azioni
#1142
Exact Sciences Corporation specializes in developing and distributing cancer... Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the Oncotype DX family of gene expression tests, designed for breast, prostate, and colon cancers. Within this suite, the Oncotype Test provides detailed tumor profiling from tissue samples, assisting in treatment selection for individuals battling advanced, metastatic, refractory, or recurrent cancers. Furthermore, they offer the Oncotype DX AR-V7 Nucleus Detect Test, a liquid biopsy designed for advanced-stage prostate cancer patients, and Oncomap ExTra, which delivers a comprehensive biological insight into challenging, rare, or aggressive malignancies. Exact Sciences also provides COVID-19 testing services. Future initiatives involve enhancing Cologuard's performance characteristics and pioneering novel blood- and other fluid-based diagnostic tests. The company maintains important license agreements with the MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, Exact Sciences Corporation's corporate headquarters are located in Madison, Wisconsin.
Prezzo delle azioni
$104.91
Ultima sincronizzazione: 2026-03-23
Capitalizzazione di mercato
$20.03B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
65.45%
Paese
US
Scambia Exact Sciences Corporation (EXAS)
Categoria
Healthcare
Storico del prezzo dell'azione per Exact Sciences Corporation (EXAS)
Prezzo di chiusura più alto: $103.73 il 2026-03-01
Prezzo di chiusura più basso: $12.01 il 2001-02-01
Prezzo di chiusura più basso: $12.01 il 2001-02-01
Storico del prezzo dell'azione di Exact Sciences Corporation dal 2001 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -6.38% |
| 2025 | 69.09% |
| 2024 | -12.49% |
| 2023 | 42.90% |
| 2022 | -39.16% |
| 2021 | -40.80% |
| 2020 | 48.89% |
| 2019 | 34.19% |
| 2018 | 25.30% |
| 2017 | 281.21% |
| 2016 | 57.59% |
| 2015 | -67.41% |
| 2014 | 124.59% |
| 2013 | 17.94% |
| 2012 | 26.41% |
| 2011 | 36.65% |
| 2010 | 107.64% |
| 2009 | 526.88% |
| 2008 | -86.19% |
| 2007 | 44.84% |
| 2006 | 26.38% |
| 2005 | -51.35% |
| 2004 | -60.90% |
| 2003 | -11.30% |
| 2002 | 12.77% |
| 2001 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $694.53 | 24.47% |
US
|
|
| $234.00 | 5.99% |
US
|
|
| $416.01 | 122.61% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.93 | 22.13% |
US
|
